Research Topics
| Erik R DubberkeSummaryAffiliation: Washington University School of Medicine Country: USA Publications
| Collaborators
|
Detail Information
Publications
Burden of Clostridium difficile on the healthcare systemErik R Dubberke
Department of Medicine, Washington University School of Medicine, St Louis, Missouri, USA
Clin Infect Dis 55:S88-92. 2012....
Clostridium difficile infection: the scope of the problemErik Dubberke
Division of Infectious Disease, Washington University School of Medicine, St Louis, Missouri 63110, USA
J Hosp Med 7:S1-4. 2012..The 3 articles that follow in this supplement address the diagnosis and treatment of initial and recurrent CDI, and current practice guidelines for the prevention and control of CDI in the hospital setting...
Strategies for prevention of Clostridium difficile infectionErik Dubberke
Division of Infectious Disease, Washington University School of Medicine, St Louis, Missouri 63110, USA
J Hosp Med 7:S14-7. 2012..difficile, and antibiotic stewardship. Hospitalists, as coordinators of care for each patient and advocates for quality care, can spearhead these efforts...
Implementing automated surveillance for tracking Clostridium difficile infection at multiple healthcare facilitiesErik R Dubberke
Washington University School of Medicine, St Louis, MO 63110, USA
Infect Control Hosp Epidemiol 33:305-8. 2012..Electronic surveillance was highly sensitive, specific, and showed good to excellent agreement for hospital-onset; community-onset, study facility-associated; indeterminate; and recurrent CDI...
Prevention of healthcare‐associated Clostridium difficile infection: what works?Erik R Dubberke
Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine, 660 S Euclid Avenue, St Louis, MO 63110, USA
Infect Control Hosp Epidemiol 31:S38-41. 2010..difficile infection. Studies are needed to define the optimal prevention practices and to investigate novel prevention methods...
Impact of clinical symptoms on interpretation of diagnostic assays for Clostridium difficile infectionsErik R Dubberke
Department of Medicine, Washington University School of Medicine, 660 S Euclid, Box 8051, St Louis, MO 63110, USA
J Clin Microbiol 49:2887-93. 2011..None suffered from any CDI-related adverse events. In conclusion, clinical presentation is important when interpreting C. difficile diagnostic assays...
Development and validation of a Clostridium difficile infection risk prediction modelErik R Dubberke
Washington University School of Medicine, St Louis, Missouri, USA
Infect Control Hosp Epidemiol 32:360-6. 2011..To develop and validate a risk prediction model that could identify patients at high risk for Clostridium difficile infection (CDI) before they develop disease...
Multicenter study of Clostridium difficile infection rates from 2000 to 2006Erik R Dubberke
Department of Medicine, Washington University School of Medicine, Box 8051, 660 South Euclid, St Louis, MO 63110, USA
Infect Control Hosp Epidemiol 31:1030-7. 2010....
Hospital-associated Clostridium difficile infection: is it necessary to track community-onset disease?Erik R Dubberke
Washington University School of Medicine, St Louis, Missouri, USA
Infect Control Hosp Epidemiol 30:332-7. 2009....
Multicenter study of surveillance for hospital-onset Clostridium difficile infection by the use of ICD-9-CM diagnosis codesErik R Dubberke
Washington University School of Medicine, St Louis, Missouri, USA
Infect Control Hosp Epidemiol 31:262-8. 2010..difficile toxin assay results...
Multicenter study of the impact of community-onset Clostridium difficile infection on surveillance for C. difficile infectionErik R Dubberke
Department of Medicine, Washington University School of Medicine, St Louis, Missouri 63110, USA
Infect Control Hosp Epidemiol 30:518-25. 2009..To evaluate the impact of cases of community-onset, healthcare facility (HCF)-associated Clostridium difficile infection (CDI) on the incidence and outbreak detection of CDI...
The impact of ICD-9-CM code rank order on the estimated prevalence of Clostridium difficile infectionsErik R Dubberke
Department of Medicine, Washington University School of Medicine, St Louis, Missouri 63110, USA
Clin Infect Dis 53:20-5. 2011..Whether ICD-9-CM code rank order affects CDI prevalence estimates is important because the National Hospital Discharge Survey (NHDS) and the Nationwide Inpatient Sample (NIS) have varying limits on the number of ICD-9-CM codes collected...
Identification of a pseudo-outbreak of Clostridium difficile infection (CDI) and the effect of repeated testing, sensitivity, and specificity on perceived prevalence of CDIMarina Litvin
Department of Medicine, Washington University School of Medicine, Barnes Jewish Hospital, St Louis, Missouri 63110, USA
Infect Control Hosp Epidemiol 30:1166-71. 2009..difficile on perceived CDI burden, positive predictive value, and false-positive results...
Attributable outcomes of endemic Clostridium difficile-associated disease in nonsurgical patientsErik R Dubberke
Washington University School of Medicine, St Louis, Missouri, USA
Emerg Infect Dis 14:1031-8. 2008..Even in a nonoutbreak setting, CDAD had a statistically significant negative impact on patient illness and death, and the impact of CDAD persisted beyond hospital discharge...
A multicenter study of Clostridium difficile infection-related colectomy, 2000-2006Amelia M Kasper
Washington University School of Medicine, St Louis, Missouri, USA
Infect Control Hosp Epidemiol 33:470-6. 2012..To assess Clostridium difficile infection (CDI)-related colectomy rates by CDI surveillance definitions and over time at multiple healthcare facilities...
Recognition and prevention of hospital-associated enteric infections in the intensive care unitLinda D Bobo
Department of Medicine, Washington University School of Medicine, St Louis, MO, USA
Crit Care Med 38:S324-34. 2010..In addition, intensivists should be ready to implement systems changes related to notification, isolation precautions and prevention, and environmental cleaning in the ICU...
Clostridium difficile-associated disease in allogeneic hematopoietic stem-cell transplant recipients: risk associations, protective associations, and outcomesErik R Dubberke
Department of Medicine, Washington University School of Medicine, St Louis, MO, USA
Clin Transplant 24:192-8. 2010..6, 95% CI 1.1-6.2). CDAD is a significant cause of morbidity and mortality in allogeneic HSCT patients, but modifiable risk factors exist. Further study is needed to determine the best methods of decreasing patients' risk of CDAD...
Clostridium difficile--associated disease in a setting of endemicity: identification of novel risk factorsErik R Dubberke
Washington University School of Medicine, St Louis, Missouri, USA
Clin Infect Dis 45:1543-9. 2007..The purpose of this study was to determine risk factors for endemic CDAD, including CDAD pressure, a modified version of colonization pressure...
Short- and long-term attributable costs of Clostridium difficile-associated disease in nonsurgical inpatientsErik R Dubberke
Washington University School of Medicine, Saint Louis, Missouri, USA
Clin Infect Dis 46:497-504. 2008..There are few data on the short-term and long-term attributable costs of CDAD. The objective of this study was to determine the acute and 180-day attributable inpatient costs of CDAD...
A Clostridium difficile infection "intervention": change in toxin assay results in fewer C difficile infection cases without changes in patient outcomesZhuolin Han
Department of Medicine, Washington University School of Medicine, St Louis, MO, USA
Am J Infect Control 40:349-53. 2012..The objective of this study was to determine whether the decreased CDI incidence related to the change in EIA resulted in adverse patient outcomes...
Clostridium difficile infection in solid organ transplant recipientsDavid J Riddle
Division of Infectious Diseases, Department of Medicine, Washington University in St Louis, St Louis, Missouri 63110, USA
Curr Opin Organ Transplant 13:592-600. 2008..To provide a general understanding of Clostridium difficile infection with a focus on recent publications that evaluate the disease in solid organ transplant recipients...
Evaluation of Clostridium difficile-associated disease pressure as a risk factor for C difficile-associated diseaseErik R Dubberke
Department of Medicine, Washington University School of Medicine, St Louis, MO 63110, USA
Arch Intern Med 167:1092-7. 2007..The purpose of this study was to evaluate CDAD pressure, a modified form of colonization pressure based on symptomatic CDAD cases, as a risk factor for CDAD...
Incidence of Clostridium difficile infection in inflammatory bowel diseaseJoseph F Rodemann
Division of Gastroenterology, Department of Medicine, Washington University School of Medicine, St Louis, Missouri 63110, USA
Clin Gastroenterol Hepatol 5:339-44. 2007..We sought to determine whether CDAD incidence has increased specifically in hospitalized patients with IBD. We also explored possible differences in the risk for and time to presentation of CDAD between IBD and non-IBD patients...
Prevalence of Clostridium difficile environmental contamination and strain variability in multiple health care facilitiesErik R Dubberke
Division of Infectious Diseases, Washington University School of Medicine, St Louis, MO 63110, USA
Am J Infect Control 35:315-8. 2007..difficile environmental contamination at various health care facilities in a metropolitan area and determine if the North American pulsed field gel electrophoresis type 1 (NAP1) strain was present...
Clostridium difficile in the ICU: the struggle continuesLinda D Bobo
Adult Infectious Diseases Division, University School of Medicine, St Louis, MO, USA
Chest 140:1643-53. 2011....
Use of cytomegalovirus intravenous immune globulin for the adjunctive treatment of cytomegalovirus in hematopoietic stem cell transplant recipientsBryan T Alexander
Department of Pharmacy, Barnes Jewish Hospital, Washington University School of Medicine, St Louis, Missouri 63110, USA
Pharmacotherapy 30:554-61. 2010..To describe the characteristics and clinical outcomes of hematopoietic stem cell transplant (HSCT) recipients who received adjunctive cytomegalovirus intravenous immune globulin (CMV-IVIG) for probable or proven CMV disease...
MAPK-activated protein kinase 2 contributes to Clostridium difficile-associated inflammationLinda D Bobo
Departments of Pediatrics, Washington University School of Medicine, StLouis, Missouri, USA
Infect Immun 81:713-22. 2013..Activation of p38-MK2 in infected animals and humans suggests that this pathway is a key driver of intestinal inflammation in patients with CDI...
Risk factors associated with methicillin-resistant Staphylococcus aureus colonization on hospital admission among oncology patientsAdam M Schaefer
Barnes Jewish Hospital, St Louis, MO, USA
Am J Infect Control 37:603-5. 2009..Risk factors for any S aureus and MRSA colonization on admission in oncology patients are consistent with previous studies in general populations. In addition, recent chemotherapy as a risk factor is a unique finding in this population...
Clostridium difficile infection in the intensive care unitDavid J Riddle
Division of Infectious Diseases, Departments of Medicine and Pediatrics, Washington University School of Medicine, 660 S Euclid Avenue, Campus Box 8051, St Louis, MO 63110 1093, USA
Infect Dis Clin North Am 23:727-43. 2009..This article seeks to provide a broad understanding of CDI in the intensive care unit, with special emphasis on risk factor identification, treatment options, and disease prevention...
Severity of Clostridium difficile-associated disease (CDAD) in allogeneic stem cell transplant recipients: evaluation of a CDAD severity grading systemErik R Dubberke
Division of Infectious Diseases, Washington University School of Medicine, St Louis, MO 63110, USA
Infect Control Hosp Epidemiol 28:208-11. 2007..Patients with severe CDAD had significantly shorter median survival times and more adverse outcomes than patients with mild or moderate CDAD...
Review of current literature on the economic burden of Clostridium difficile infectionErik R Dubberke
Infectious Diseases Division, Department of Medicine, Washington University in St Louis, School of Medicine, St Louis, Missouri 63110, USA
Infect Control Hosp Epidemiol 30:57-66. 2009..To more completely assess its economic burden, we performed a review of available literature that reported costs associated with the infection...
Case-control study of clinical features of influenza in hospitalized patientsHilary M Babcock
Washington University School of Medicine, Infectious Diseases Division, St Louis, Missouri 63110, USA
Infect Control Hosp Epidemiol 29:921-6. 2008..Few data exist on the clinical presentation of influenza in hospitalized patients, which may be distinct from the clinical presentation of influenza in ambulatory patients because of underlying medical conditions and medications...
Micafungin for the prophylaxis and treatment of Candida infectionsJoseph M Fritz
Washington University School of Medicine, Division of Infectious Diseases, Department of Internal Medicine, 660 South Euclid Avenue, Campus Box 8051, St Louis, MO 63110, USA
Expert Rev Anti Infect Ther 6:153-62. 2008..In general, micafungin is well tolerated and has favorable safety and drug-interaction profiles...
Acute meningoencephalitis caused by adenovirus serotype 26Erik R Dubberke
Department of Medicine, Washington University School of Medicine, St Louis, Missouri 63110, USA
J Neurovirol 12:235-40. 2006..In this article the authors report a case of adenoviral meningoencephalitis caused by serotype 26 and its identification, not described previously, in cerebrospinal fluid (CSF) by PCR and brain tissue by immunohistochemical staining...
Assessing colectomies due to Clostridium difficile infection: increases in the community, but not in the referral centerKathleen M McMullen
Infection Prevention, Barnes Jewish Hospital, St Louis, MO, USA
Am J Infect Control 40:778-80. 2012..The investigation found an increase in CDI-related colectomies for CDI not associated with the study institution. Electronically available data facilitated surveillance for severe CDI...
Assessment of an alternative meropenem dosing strategy compared with imipenem-cilastatin or traditional meropenem dosing after cefepime failure or intolerance in adults with neutropenic feverHeather M Arnold
Department of Pharmacy, Barnes Jewish Hospital, St Louis, Missouri 63110, USA
Pharmacotherapy 29:914-23. 2009....
A systematic evaluation of methods to optimize culture-based recovery of Clostridium difficile from stool specimensTiffany Hink
Department of Medicine, Washington University School of Medicine, St Louis, MO 63110, USA
Anaerobe 19:39-43. 2013..Sparks, MD). Identifying the most sensitive method of recovery will allow for further study of asymptomatic C. difficile carriers and their role in the epidemiology of C. difficile...
ICD-9 codes and surveillance for Clostridium difficile-associated diseaseErik R Dubberke
Washington University in St Louis School of Medicine, Saint Louis, Missouri, USA
Emerg Infect Dis 12:1576-9. 2006..The correlation between toxin assay results and ICD-9 codes was good (K = 0.72, p<0.01). The sensitivity of the ICD-9 codes was 78% and the specificity was 99.7%...
Development and evaluation of a novel, semiautomated Clostridium difficile typing platformLars F Westblade
Department of Pathology and Immunology, Washington University School of Medicine in St Louis, St Louis, Missouri, USA
J Clin Microbiol 51:621-4. 2013..The platform is reproducible with minimal intra- or interassay variability. This method exhibited a discriminatory index of 0.954 and is therefore comparable to more arduous typing systems, such as pulsed-field gel electrophoresis...
A woman from Honduras with a painful forearm and feverErik R Dubberke
Infectious Diseases Division, Department of Internal Medicine, Washington University School of Medicine, St. Louis, Missouri 63110, USA
Am J Trop Med Hyg 78:697-8. 2008
